This paper is in the following e-collection/theme issue:

Lung Cancer (47) Registered Report (668) Cancer Survivorship (283) Health Services Research in Oncology (43) Cancer and Clinical Trials (29)

Published on in Vol 11 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/65118, first published .
Treatment Outcomes From Erlotinib and Gefitinib in Advanced Epidermal Growth Factor Receptor–Mutated Nonsquamous Non–Small Cell Lung Cancer in Aotearoa New Zealand From 2010 to 2020: Nationwide Whole-of-Patient-Population Retrospective Cohort Study

Treatment Outcomes From Erlotinib and Gefitinib in Advanced Epidermal Growth Factor Receptor–Mutated Nonsquamous Non–Small Cell Lung Cancer in Aotearoa New Zealand From 2010 to 2020: Nationwide Whole-of-Patient-Population Retrospective Cohort Study

Treatment Outcomes From Erlotinib and Gefitinib in Advanced Epidermal Growth Factor Receptor–Mutated Nonsquamous Non–Small Cell Lung Cancer in Aotearoa New Zealand From 2010 to 2020: Nationwide Whole-of-Patient-Population Retrospective Cohort Study

Authors of this article:

Phyu Sin Aye1 Author Orcid Image ;   Joanne Barnes2 Author Orcid Image ;   George Laking3 Author Orcid Image ;   Laird Cameron4 Author Orcid Image ;   Malcolm Anderson5 Author Orcid Image ;   Brendan Luey6 Author Orcid Image ;   Stephen Delany7 Author Orcid Image ;   Dean Harris8 Author Orcid Image ;   Blair McLaren9 Author Orcid Image ;   Elliott Brenman10 Author Orcid Image ;   Jayden Wong11 Author Orcid Image ;   Ross Lawrenson12 Author Orcid Image ;   Michael Arendse13 Author Orcid Image ;   Sandar Tin Tin14 Author Orcid Image ;   Mark Elwood14 Author Orcid Image ;   Philip Hope15 Author Orcid Image ;   Mark James McKeage1 Author Orcid Image
Article Authors Cited by Tweetations Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.